Luis Chavez, MD
Internal Medicine · San Diego, CANPI 1295224905
Payments from drug & device makers
Across 96 payments — averaging $35.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wilson Cook Medical Incorporated$773
- Takeda Pharmaceuticals U.S.A., Inc.$414
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$323
- Gilead$314
- Madrigal Pharmaceuticals$296
- AbbVie$263
- plus $1K from 12 others
What the payments were for
- Travel & lodging$88526%
- Food & beverage$2,56174%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wilson Cook Medical Incorporated | 3 | $773 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $414 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $323 |
| Gilead | 3 | $314 |
| Madrigal Pharmaceuticals | 4 | $296 |
| AbbVie | 18 | $263 |
| Cook Medical LLC | 4 | $214 |
| Ardelyx, Inc. | 6 | $174 |
| Intercept Pharmaceuticals, Inc. | 6 | $162 |
| Phathom Pharmaceuticals, Inc. | 2 | $135 |
| Medtronic | 3 | $84 |
| Sanofi | 2 | $71 |
| Pfizer | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Celltrion USA Inc. | 2 | $38 |
| Boston Scientific | 2 | $31 |
| Olympus America Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FUSION$854
- RESMETIROM$258
- VOQUEZNA$125
- Epclusa$116
- OCALIVA$105
How this compares
$3,447 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 63 | $770 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $713 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 36 | $576 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 33 | $506 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $202 |
| Dicyclomine Hcl | 12 | $172 |
| Omeprazole | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Diego
- Donald BrandonSan Diego$34M
- Elaine WatkinsSan Diego$11.3M
- James ChenSan Diego$2.9M
- Rita StarrittSan Diego$2.6M
- Hatim HusainSan Diego$2.6M
- Gary FiresteinSan Diego$2.6M
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.